about
Trafficking pathways of mycolic acids: structures, origin, mechanism of formation, and storage form of mycobacteric acids.Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice.New variants of polar glycopeptidolipids detected in Mycobacterium simiae, including 'habana' strains, as evidenced by electrospray ionization-ion trap-mass spectrometry.Analysis of the structure of mycolic acids of Mycobacterium simiae reveals a particular composition of alpha-mycolates in strain 'habana' TMC 5135, considered as immunogenic in tuberculosis and leprosy.Structural studies of cord factors from Mycobacterium simiae related to the capacity for tumour necrosis factor alpha (α-TNF) induction.Cord factors from atypical mycobacteria (Mycobacterium alvei, Mycobacterium brumae) stimulate the secretion of some pro-inflammatory cytokines of relevance in tuberculosis.Ether-linked lipids of Dermabacter hominis, a human skin actinobacterium.Microbiological characterization and clinical significance of Corynebacterium amycolatum strains.Characterization of acyl-phosphatidylinositol from the opportunistic pathogen Corynebacterium amycolatum.Identification ofClostridium difficile by detection of p-cresol in a cooked meat mediumBordetella hinzii, a “new” Opportunistic Pathogen to Think AboutTaxonomic implications of the chemical analysis of the D2 group of corynebacteriaA gas-liquid and thin-layer chromatographic study of Mycobacterium fortuitumAcyl phosphatidylglycerol: a major phospholipid of Corynebacterium amycolatumDetection of mycoloylglycerol by thin-layer chromatography as a tool for the rapid inclusion of corynebacteria of clinical origin in the genus Corynebacterium3-Hydroxy fatty acids in saliva as diagnostic markers in chronic periodontitisComparative Metabolomics between Mycobacterium tuberculosis and the MTBVAC Vaccine Candidate
P50
Q33366937-53C3C600-FEB4-4A03-9979-D792F6AB0684Q36277455-188F3386-F14D-4169-979E-0D74FF34C7C6Q39239493-729D320D-0974-4470-B7A3-ECC6C238703AQ39239503-FB78C0E9-66F2-4492-AA23-36B756243D13Q39239513-7531B260-8DFD-4193-83E4-023732131CCFQ39278893-3A047524-7958-484C-A19C-3316885B4CB0Q40795058-39843D6E-288B-4259-8FA6-29E29A6FE91BQ44425136-D9931F43-FC9F-4D5F-A02F-D2AD16F4F268Q45180963-96A14DEB-C3BF-49B6-91A7-8CD9D2CF862AQ60214701-64ED0804-FC93-4306-852B-7DAB790CEBC7Q61704619-B6C18B36-F6BB-4EA7-8C5C-DF9EDFE82A56Q70260983-992B8208-6D8F-44FD-8F06-59A6820E76B4Q71157537-20B33A1A-9F37-4DC9-AA6E-14434E681B97Q73522413-D9DFF627-5B91-48B7-8EF2-CE36CF8F23C4Q73707331-25131CFB-B998-4C0E-8969-47452172482AQ81822926-F727E772-F605-4668-8889-7F7D66747A20Q92105293-8F71FE58-2505-49EB-AC85-98533482A8E9
P50
description
researcher, ORCID id # 0000-0003-1014-0595
@en
wetenschapper
@nl
name
Pedro Valero-Guillén
@ast
Pedro Valero-Guillén
@en
Pedro Valero-Guillén
@es
Pedro Valero-Guillén
@nl
type
label
Pedro Valero-Guillén
@ast
Pedro Valero-Guillén
@en
Pedro Valero-Guillén
@es
Pedro Valero-Guillén
@nl
prefLabel
Pedro Valero-Guillén
@ast
Pedro Valero-Guillén
@en
Pedro Valero-Guillén
@es
Pedro Valero-Guillén
@nl
P106
P1153
6701356174
P21
P31
P496
0000-0003-1014-0595